Stability of warfarin sodium flavoured preservative-free oral liquid formulations

被引:3
|
作者
Schlatter, Joel [1 ]
Cisternino, Salvatore [1 ,2 ]
机构
[1] Hop Univ Necker Enfants Malad, Pharm Clin, Paris, France
[2] Univ Paris 05, Fac Pharm, UMR S 1144, Paris, France
关键词
formulation; pediatric; preservative-free; sodium warfarin; stability;
D O I
10.1136/ejhpharm-2017-001281
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives This study was designed to assess the physicochemical stability of warfarin sodium liquid formulations stored at room temperature and under refrigeration. Methods Formulations of warfarin sodium 1mg/mL were prepared from either powder or tablets dispersed in mixture containing deionised water, glycerin, sodium phosphate and strawberry alcohol-free concentrate flavour and stored in amber glass bottles at 25 degrees C and 4 degrees C. Stability indicating high-performance liquid chromatography assay procedure was used to analyse the concentration of the drug at the time of preparation and on days 7, 14, 21, 30, 45, 60 and 90. Changes in colour, taste and pH, as well as visual evidence of precipitation, were assessed for physicochemical instability. Results Between day 0 and day 90, the pH of the powder and tablet formulations stored at 25 degrees C decreased by -1.40 units and -1.16 units, respectively. There were minor changes in pH for both formulations stored at 4 degrees C. The formulation from powder stored at 25 degrees C and 4 degrees C maintained at least 90% of the initial warfarin concentration for 30 days and 45 days, respectively. The formulation from tablets stored at 25 degrees C and 4 degrees C maintained at least 90% of initial warfarin concentration for 21 days and 30 days, respectively. Conclusion Warfarin sodium in flavoured preservativefree formulation from powder is recommended and stable in amber glass bottles for at least 30 days stored at 25 degrees C and 45 days stored at 4 degrees C.
引用
收藏
页码:E98 / E101
页数:4
相关论文
共 50 条
  • [31] Evaluation of a preservative-free, cross-linked sodium hyaluronate-based solution, Lacri plus ®, in dogs with dry eye: a pilot trial
    Gard, Carole
    Cassagnes, Charles
    Muller, Sarah
    Navarro, Christelle
    Jahier, Bruno
    IRISH VETERINARY JOURNAL, 2023, 76 (01)
  • [32] Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules
    Winiarski, Aleksander P.
    Infeld, Martin H.
    Tscherne, Ronald
    Bachynsky, Maria
    Rucki, Richard
    Nagano-Mate, Kathy
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2007, 47 (06) : 747 - 755
  • [33] SOME OBSERVATIONS ON STABILITY OF VITAMINS A B1 + C IN ORAL LIQUID FORMULATIONS
    SABRI, MI
    RAO, VKM
    INDIAN JOURNAL OF TECHNOLOGY, 1964, 2 (01): : 30 - &
  • [34] A Preservative-Free Combination of Sodium Hyaluronate and Trehalose Improves Dry Eye Signs and Symptoms and Increases Patient Satisfaction in Real-Life Settings: The TEARS Study
    Mateo-Orobia, Antonio J.
    Farrant, Sarah
    Del-Prado-Sanz, Eduardo
    Blasco-Martinez, Alejandro
    Idoipe-Corta, Miriam
    Lafuente-Ojeda, Noelia
    Pablo-Julvez, Luis E.
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (12) : 3123 - 3134
  • [35] Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients
    Merino-Bohorquez, V.
    Delgado-Valverde, M.
    Garcia-Palomo, M.
    Davila-Pousa, M. C.
    Canete, C.
    Villaronga, M.
    Rodriguez-Marrodan, B.
    Lopez-Rojas, R.
    Camean-Fernandez, M.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2019, 24 (04) : 465 - 478
  • [36] Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome
    Jee, Donghyun
    Park, Minji
    Lee, Hee Jin
    Kim, Man Soo
    Kim, Eun Chul
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2015, 41 (04): : 756 - 763
  • [37] Correction: A Preservative-Free Combination of Sodium Hyaluronate and Trehalose Improves Dry Eye Signs and Symptoms and Increases Patient Satisfaction in Real-Life Settings: The TEARS Study
    Antonio J. Mateo-Orobia
    Sarah Farrant
    Eduardo Del-Prado-Sanz
    Alejandro Blasco-Martínez
    Miriam Idoipe-Corta
    Noelia Lafuente-Ojeda
    Luis E. Pablo-Júlvez
    Ophthalmology and Therapy, 2025, 14 (5) : 1169 - 1171
  • [38] In vitro compatibility study of a new preservative-free multidose 0.6% bilastine eye drop formulation containing sodium hyaluronate with soft and gas rigid permeable contact lenses
    Rey, Eider Arana
    Cortes, Tatiana Suarez
    Gonzalo, Ana
    Victoriano, Noelia Andollo
    Prat, Ines Torrens
    Zazpe, Arturo
    Hernandez, Gonzalo
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [39] Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus
    Estevez, Pablo
    Boscolo, Oriana
    Quiroga, Eduardo
    Fernandez Penuto, Rocio
    Buontempo, Fabian
    Tripodi, Valeria
    Lucangioli, Silvia
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2016, 23 (04) : 213 - 218
  • [40] Stability of mycophenolate mofetil in an extemporaneously compounded sugar-free oral liquid
    Swensow, CF
    Dentinger, PJ
    Anaizi, NH
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (21) : 2224 - 2226